Compare DXR & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DXR | CPIX |
|---|---|---|
| Founded | 1970 | 1999 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.4M | 59.5M |
| IPO Year | N/A | N/A |
| Metric | DXR | CPIX |
|---|---|---|
| Price | $12.40 | $3.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | 7.4K | ★ 198.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $34.39 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.00 | $1.85 |
| 52 Week High | $14.76 | $7.25 |
| Indicator | DXR | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 45.27 | 47.37 |
| Support Level | $12.15 | $3.68 |
| Resistance Level | $12.90 | $3.98 |
| Average True Range (ATR) | 0.44 | 0.26 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 16.67 | 50.43 |
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.